A citation-based method for searching scientific literature

Habib Sadeghi Rad, James Monkman, Majid E Warkiani, Rahul Ladwa, Ken O'Byrne, Nima Rezaei, Arutha Kulasinghe. Med Res Rev 2021
Times Cited: 9







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.
Naiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa S Ho,[...]. Science 2015
33

Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy.
Yuting Liu, Jon Zugazagoitia, Fahad Shabbir Ahmed, Brian S Henick, Scott N Gettinger, Roy S Herbst, Kurt A Schalper, David L Rimm. Clin Cancer Res 2020
60
22

Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence.
Samuel J Klempner, David Fabrizio, Shalmali Bane, Marcia Reinhart, Tim Peoples, Siraj M Ali, Ethan S Sokol, Garrett Frampton, Alexa B Schrock, Rachel Anhorn,[...]. Oncologist 2020
55
22

CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.
Masao Hashimoto, Alice O Kamphorst, Se Jin Im, Haydn T Kissick, Rathi N Pillai, Suresh S Ramalingam, Koichi Araki, Rafi Ahmed. Annu Rev Med 2018
216
22

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape.
Janis M Taube, Robert A Anders, Geoffrey D Young, Haiying Xu, Rajni Sharma, Tracee L McMiller, Shuming Chen, Alison P Klein, Drew M Pardoll, Suzanne L Topalian,[...]. Sci Transl Med 2012
22


Mutational heterogeneity in cancer and the search for new cancer-associated genes.
Michael S Lawrence, Petar Stojanov, Paz Polak, Gregory V Kryukov, Kristian Cibulskis, Andrey Sivachenko, Scott L Carter, Chip Stewart, Craig H Mermel, Steven A Roberts,[...]. Nature 2013
22

Natural killer cells and other innate lymphoid cells in cancer.
Laura Chiossone, Pierre-Yves Dumas, Margaux Vienne, Eric Vivier. Nat Rev Immunol 2018
339
22

Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms.
Rong En Tay, Emma K Richardson, Han Chong Toh. Cancer Gene Ther 2021
90
22

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
Cyril Neftel, Julie Laffy, Mariella G Filbin, Toshiro Hara, Marni E Shore, Gilbert J Rahme, Alyssa R Richman, Dana Silverbush, McKenzie L Shaw, Christine M Hebert,[...]. Cell 2019
399
22

An anatomic transcriptional atlas of human glioblastoma.
Ralph B Puchalski, Nameeta Shah, Jeremy Miller, Rachel Dalley, Steve R Nomura, Jae-Guen Yoon, Kimberly A Smith, Michael Lankerovich, Darren Bertagnolli, Kris Bickley,[...]. Science 2018
160
22

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
22

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
22

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.
Anoop P Patel, Itay Tirosh, John J Trombetta, Alex K Shalek, Shawn M Gillespie, Hiroaki Wakimoto, Daniel P Cahill, Brian V Nahed, William T Curry, Robert L Martuza,[...]. Science 2014
22

The evolving landscape of predictive biomarkers in immuno-oncology with a focus on spatial technologies.
Habib Sadeghi Rad, Sajad Razavi Bazaz, James Monkman, Majid Ebrahimi Warkiani, Nima Rezaei, Ken O'Byrne, Arutha Kulasinghe. Clin Transl Immunology 2020
6
33

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, Victoria Wang, Yuan Qi, Matthew D Wilkerson, C Ryan Miller, Li Ding, Todd Golub, Jill P Mesirov,[...]. Cancer Cell 2010
22

Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages.
Stefano Ugel, Francesco De Sanctis, Susanna Mandruzzato, Vincenzo Bronte. J Clin Invest 2015
303
11

The opposing roles of CD4+ T cells in anti-tumour immunity.
Tomasz Ahrends, Jannie Borst. Immunology 2018
28
11

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.
Diego Chowell, Luc G T Morris, Claud M Grigg, Jeffrey K Weber, Robert M Samstein, Vladimir Makarov, Fengshen Kuo, Sviatoslav M Kendall, David Requena, Nadeem Riaz,[...]. Science 2018
419
11

Regulation and Function of the PD-L1 Checkpoint.
Chong Sun, Riccardo Mezzadra, Ton N Schumacher. Immunity 2018
596
11

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.
Martin P Barr, Steven G Gray, Kathy Gately, Emily Hams, Padraic G Fallon, Anthony Mitchell Davies, Derek J Richard, Graham P Pidgeon, Kenneth J O'Byrne. Mol Cancer 2015
44
11


Tcf1 and Lef1 transcription factors establish CD8(+) T cell identity through intrinsic HDAC activity.
Shaojun Xing, Fengyin Li, Zhouhao Zeng, Yunjie Zhao, Shuyang Yu, Qiang Shan, Yalan Li, Farrah C Phillips, Peterson K Maina, Hank H Qi,[...]. Nat Immunol 2016
105
11


Human Mast Cell Proteome Reveals Unique Lineage, Putative Functions, and Structural Basis for Cell Ablation.
Thomas Plum, Xi Wang, Mandy Rettel, Jeroen Krijgsveld, Thorsten B Feyerabend, Hans-Reimer Rodewald. Immunity 2020
39
11

CAR-T cells: the long and winding road to solid tumors.
Maria Michela D'Aloia, Ilaria Grazia Zizzari, Benedetto Sacchetti, Luca Pierelli, Maurizio Alimandi. Cell Death Dis 2018
180
11

EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma.
Gang Xiao, Li-Lian Jin, Chao-Qun Liu, Yong-Chun Wang, Ya-Ming Meng, Zhong-Guo Zhou, Jing Chen, Xing-Juan Yu, Yao-Jun Zhang, Jing Xu,[...]. J Immunother Cancer 2019
49
11

Harnessing Natural Killer Immunity in Metastatic SCLC.
Sarah A Best, Jonas B Hess, Fernando Souza-Fonseca-Guimaraes, Joseph Cursons, Ariena Kersbergen, Xueyi Dong, Jai Rautela, Stephanie R Hyslop, Matthew E Ritchie, Melissa J Davis,[...]. J Thorac Oncol 2020
12
11

Drug development: Releasing the brakes.
Karen Weintraub. Nature 2013
14
11

Targeting Tumor-Associated Macrophages in Cancer.
Paulina Pathria, Tiani L Louis, Judith A Varner. Trends Immunol 2019
266
11

CD4+ T cell help in cancer immunology and immunotherapy.
Jannie Borst, Tomasz Ahrends, Nikolina Bąbała, Cornelis J M Melief, Wolfgang Kastenmüller. Nat Rev Immunol 2018
372
11

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.
Cyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, Katerina Shamalov, Kasia Trebska-McGowan, Valery V Bliskovsky, Maria R Parkhurst, Chen Ankri, Todd D Prickett, Jessica S Crystal,[...]. J Clin Invest 2015
225
11

Perforin and granzymes: function, dysfunction and human pathology.
Ilia Voskoboinik, James C Whisstock, Joseph A Trapani. Nat Rev Immunol 2015
421
11

Fas/FasL signaling is critical for the survival of exhausted antigen-specific CD8+ T cells during tumor immune response.
Toshiki Yajima, Kouki Hoshino, Ryo Muranushi, Akira Mogi, Ryoichi Onozato, Ei Yamaki, Takayuki Kosaka, Shigebumi Tanaka, Ken Shirabe, Yasunobu Yoshikai,[...]. Mol Immunol 2019
6
16


Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
Jedd D Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, Piotr Rutkowski, Jean-Jacques Grob, C Lance Cowey, Christopher D Lao, John Wagstaff, Dirk Schadendorf, Pier F Ferrucci,[...]. N Engl J Med 2017
11

TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
Sébastien Viel, Antoine Marçais, Fernando Souza-Fonseca Guimaraes, Roisin Loftus, Jessica Rabilloud, Morgan Grau, Sophie Degouve, Sophia Djebali, Amélien Sanlaville, Emily Charrier,[...]. Sci Signal 2016
252
11

Adoptive cell transfer as personalized immunotherapy for human cancer.
Steven A Rosenberg, Nicholas P Restifo. Science 2015
11

Migratory CD11b+ conventional dendritic cells induce T follicular helper cell-dependent antibody responses.
Jayendra Kumar Krishnaswamy, Uthaman Gowthaman, Biyan Zhang, Johan Mattsson, Louis Szeponik, Dong Liu, Renee Wu, Theresa White, Samuele Calabro, Lan Xu,[...]. Sci Immunol 2017
104
11

Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells.
Marco De Simone, Alberto Arrigoni, Grazisa Rossetti, Paola Gruarin, Valeria Ranzani, Claudia Politano, Raoul J P Bonnal, Elena Provasi, Maria Lucia Sarnicola, Ilaria Panzeri,[...]. Immunity 2016
264
11

The Damaging Effect of Passenger Mutations on Cancer Progression.
Christopher D McFarland, Julia A Yaglom, Jonathan W Wojtkowiak, Jacob G Scott, David L Morse, Michael Y Sherman, Leonid A Mirny. Cancer Res 2017
45
11

Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
Daniel E B Swinson, J Louise Jones, Donna Richardson, Charles Wykoff, Helen Turley, Jaromir Pastorek, Nick Taub, Adrian L Harris, Kenneth J O'Byrne. J Clin Oncol 2003
223
11

Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis.
Erin A Marshall, Kevin W Ng, Sonia H Y Kung, Emma M Conway, Victor D Martinez, Elizabeth C Halvorsen, David A Rowbotham, Emily A Vucic, Adam W Plumb, Daiana D Becker-Santos,[...]. Mol Cancer 2016
83
11

Regulation of CTL Infiltration Within the Tumor Microenvironment.
Sarah E Church, Jérôme Galon. Adv Exp Med Biol 2017
18
11

Driver and passenger mutations in cancer.
Julia R Pon, Marco A Marra. Annu Rev Pathol 2015
144
11

T-helper-1-cell cytokines drive cancer into senescence.
Heidi Braumüller, Thomas Wieder, Ellen Brenner, Sonja Aßmann, Matthias Hahn, Mohammed Alkhaled, Karin Schilbach, Frank Essmann, Manfred Kneilling, Christoph Griessinger,[...]. Nature 2013
405
11

Tumor mutational load predicts survival after immunotherapy across multiple cancer types.
Robert M Samstein, Chung-Han Lee, Alexander N Shoushtari, Matthew D Hellmann, Ronglai Shen, Yelena Y Janjigian, David A Barron, Ahmet Zehir, Emmet J Jordan, Antonio Omuro,[...]. Nat Genet 2019
11

Tumor Immuno-Environment in Cancer Progression and Therapy.
Pawel Kalinski, James E Talmadge. Adv Exp Med Biol 2017
9
11

Natural Killer Cells: Development, Maturation, and Clinical Utilization.
Alex M Abel, Chao Yang, Monica S Thakar, Subramaniam Malarkannan. Front Immunol 2018
266
11

TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis.
Daniele V F Tauriello, Sergio Palomo-Ponce, Diana Stork, Antonio Berenguer-Llergo, Jordi Badia-Ramentol, Mar Iglesias, Marta Sevillano, Sales Ibiza, Adrià Cañellas, Xavier Hernando-Momblona,[...]. Nature 2018
708
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.